Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Bernstein Downgrades Lam Research to Market Perform

Bernstein Downgrades Lam Research to Market Perform

Bernstein analyst Stacy Rasgon downgrades Lam Research (NASDAQ:LRCX) from Outperform to Market Perform.

byBenzinga Newsdesk

March 13, 2023

1 minute read

Bernstein analyst Stacy Rasgon downgrades Lam Research (NASDAQ:LRCX) from Outperform to Market Perform.

Analyst Ratings

Analyst Ratings for United Airlines Holdings

By Benzinga Insights

December 5, 11:02 AM

Within the last quarter, United Airlines Holdings (NASDAQ:UAL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…

UAL

Citigroup Maintains Buy on ATAI Life Sciences, Lowers Price Target to $10

By Benzinga Newsdesk

January 9, 2:01 PM

Citigroup analyst Neena Bitritto-Garg maintains ATAI Life Sciences (NASDAQ:ATAI) with a Buy and lowers the price target from $20 to $10.

ATAI

Canada House Cannabis Q2 FY23 Net Revenue Grows 27% YoY, Here Are The Details

By Vuk Zdinjak

March 24, 9:51 AM

Canada House Cannabis Group Inc. (formerly Canada House Wellness Group Inc.) (CSE: CHV) Q2 2023 net revenue was CA$7.82 million ($5.67 million), an increase of 27%, compared to CA$6.18 million in the same period in the prior year.

CSE:CHV

WeTrade Eyes ChatGPT-Style Product; Plans To Launch DEMO Version

By Anusuya Lahiri

February 8, 12:15 PM

Global software as a service provider WeTrade Group Inc (NASDAQ:WETG) prepared to conduct comprehensive, in-depth research on the use of ChatGPT style…

BABA

Bernstein Downgrades Lam Research to Market Perform

Related Posts

Analyst Ratings for United Airlines Holdings

Citigroup Maintains Buy on ATAI Life Sciences, Lowers Price Target to $10

Canada House Cannabis Q2 FY23 Net Revenue Grows 27% YoY, Here Are The Details

WeTrade Eyes ChatGPT-Style Product; Plans To Launch DEMO Version